Markets Today: the Asian close, 22 September 2026
The Asian trading day in one place: 5 stories across currencies, central banks, equities and deals, collected at the close.
Stocks & bonds
Apollo Funds US$585m for Executive Centre's Asia-Pacific Growth: The debt financing package supports the workspace operator's expansion across Asia-Pacific and the Middle East, alongside refinancing existing obligations.
Turkish Authorities Freeze Fund Executives' Assets Amid Market Turmoil: Turkiye's Justice Minister Akin Gurlek announced asset freezes for executives at several investment firms, expanding an investigation into a fund-industry crisis that has seen billions of liras wiped from market value.
Seoul Stocks Climb on Tech Strength, Samsung Electronics Up 3.26%: The Korea Composite Stock Price Index (KOSPI) advanced 0.93% to 6,958.32 on Monday, with chipmakers leading gains despite elevated crude oil prices.
Tata Group Shares Fall ₹52,000 Crore Amid Boardroom Dispute, RBI Listing Mandate: Investor losses followed Tata Trusts' opposition to N Chandrasekaran's reappointment and the Reserve Bank of India's decision pushing for a Tata Sons public listing.
IPO & deals
Iambic Therapeutics, backed by Nvidia and QIA, files for US IPO: The drug developer, which has raised $461.8 million, joins a series of biotech listings capitalising on drug advancements and M&A activity this year.
Every item above was reported and checked separately today; this wrap collects them in one place at the Asian close. Follow any headline through to the full story for the figures and their sources. The Brief carries the same day in five minutes tomorrow morning.
This article is journalism, not investment advice; consult a licensed professional before making financial decisions. Market data is indicative, may be delayed, and should be verified with your broker or exchange before use.
Comments.
Comments are moderated. We remove what is unlawful, abusive or off-topic, and and you remain responsible for what you post.
Reader comments open soon. Until then, corrections and responses go to our newsroom, and we publish what we get wrong on Corrections.